The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects

A possible link between diet and cancer has long been considered, with growing interest in phytochemicals. Soy isoflavones have been associated with a reduced risk of prostate cancer in Asian populations. Of the soy isoflavones, genistein and daidzein, in particular, have been studied, but recently,...

Full description

Bibliographic Details
Main Authors: Hans Van der Eecken, Steven Joniau, Charlien Berghen, Kato Rans, Gert De Meerleer
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/23/4856
_version_ 1797399803882110976
author Hans Van der Eecken
Steven Joniau
Charlien Berghen
Kato Rans
Gert De Meerleer
author_facet Hans Van der Eecken
Steven Joniau
Charlien Berghen
Kato Rans
Gert De Meerleer
author_sort Hans Van der Eecken
collection DOAJ
description A possible link between diet and cancer has long been considered, with growing interest in phytochemicals. Soy isoflavones have been associated with a reduced risk of prostate cancer in Asian populations. Of the soy isoflavones, genistein and daidzein, in particular, have been studied, but recently, equol as a derivative has gained interest because it is more biologically potent. Different mechanisms of action have already been studied for the different isoflavones in multiple conditions, such as breast, gastrointestinal, and urogenital cancers. Many of these mechanisms of action could also be demonstrated in the prostate, both in vitro and in vivo. This review focuses on the known mechanisms of action at the cellular level and compares them between genistein, daidzein, and equol. These include androgen- and estrogen-mediated pathways, regulation of the cell cycle and cell proliferation, apoptosis, angiogenesis, and metastasis. In addition, antioxidant and anti-inflammatory effects and epigenetics are addressed.
first_indexed 2024-03-09T01:45:23Z
format Article
id doaj.art-de1ff314621d46759494dde3f9b80845
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T01:45:23Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-de1ff314621d46759494dde3f9b808452023-12-08T15:23:08ZengMDPI AGNutrients2072-66432023-11-011523485610.3390/nu15234856The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular EffectsHans Van der Eecken0Steven Joniau1Charlien Berghen2Kato Rans3Gert De Meerleer4Department of Urology, University Hospital Brussels, 1090 Brussels, BelgiumDepartment of Urology, University Hospitals Leuven, 3000 Leuven, BelgiumDepartment of Radiation Oncology, University Hospitals Leuven, 3000 Leuven, BelgiumDepartment of Radiation Oncology, University Hospitals Leuven, 3000 Leuven, BelgiumDepartment of Radiation Oncology, University Hospitals Leuven, 3000 Leuven, BelgiumA possible link between diet and cancer has long been considered, with growing interest in phytochemicals. Soy isoflavones have been associated with a reduced risk of prostate cancer in Asian populations. Of the soy isoflavones, genistein and daidzein, in particular, have been studied, but recently, equol as a derivative has gained interest because it is more biologically potent. Different mechanisms of action have already been studied for the different isoflavones in multiple conditions, such as breast, gastrointestinal, and urogenital cancers. Many of these mechanisms of action could also be demonstrated in the prostate, both in vitro and in vivo. This review focuses on the known mechanisms of action at the cellular level and compares them between genistein, daidzein, and equol. These include androgen- and estrogen-mediated pathways, regulation of the cell cycle and cell proliferation, apoptosis, angiogenesis, and metastasis. In addition, antioxidant and anti-inflammatory effects and epigenetics are addressed.https://www.mdpi.com/2072-6643/15/23/4856isoflavonegenisteindaidzeinequolprostate cancer
spellingShingle Hans Van der Eecken
Steven Joniau
Charlien Berghen
Kato Rans
Gert De Meerleer
The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
Nutrients
isoflavone
genistein
daidzein
equol
prostate cancer
title The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
title_full The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
title_fullStr The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
title_full_unstemmed The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
title_short The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects
title_sort use of soy isoflavones in the treatment of prostate cancer a focus on the cellular effects
topic isoflavone
genistein
daidzein
equol
prostate cancer
url https://www.mdpi.com/2072-6643/15/23/4856
work_keys_str_mv AT hansvandereecken theuseofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT stevenjoniau theuseofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT charlienberghen theuseofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT katorans theuseofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT gertdemeerleer theuseofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT hansvandereecken useofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT stevenjoniau useofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT charlienberghen useofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT katorans useofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects
AT gertdemeerleer useofsoyisoflavonesinthetreatmentofprostatecancerafocusonthecellulareffects